Organigram Global Inc. (OGI) is a Drug manufacturers specialty generic company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Organigram Global Inc. in 2026. The next earnings report is expected on December 22, 2026.
Next earnings date
22 Dec 2026
In 123 days
EPS estimate
0.01
Revenue estimate
85.4M
Past earnings
Latest earnings analysis
Organigram Global missed consensus estimates for EPS but beat revenue expectations in its latest earnings report, with EPS of $0.1796 falling 18.6% short of expectations and revenue of $74.49 million exceeding estimates by 6.8%. In the prior report both EPS and revenue came in below expectations.
No dividend history available.
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Organigram Global Inc. (OGI) is scheduled to report earnings on December 22, 2026.
Organigram Global Inc. (OGI) last reported earnings on August 11, 2026.
Organigram Global Inc. (OGI) is listed on Nasdaq.
We use cookies to make our website work and improve your experience. With your consent, we also use cookies for analytics and advertising.